A C Mamourian1, H Young, M F Stiefel. 1. Departments of Radiology, Hospital of the University of Pennsylvania, Philadelphia 19104, USA. Alexander-.Mamourian@uphs.upenn.edu
Abstract
BACKGROUND AND PURPOSE: While considerable attention has been directed to reducing the x-ray dose of individual imaging studies, there is little information available on the cumulative dose during imaging-intensive hospitalizations. We used a radiation-sensitive badge on 12 patients admitted with SAH to determine if this approach was feasible and to measure the extent of their x-ray exposure. MATERIALS AND METHODS: After obtaining informed consent, we assigned a badge to each of 12 patients and used it for all brain imaging studies during their ICU stay. Cumulative dose was determined by quantifying exposure on the badge and correlating it with the number and type of examinations. RESULTS: The average skin dose for the 3 patients who had only diagnostic DSA without endovascular intervention was 0.4 Gy (0.2-0.6 Gy). The average skin dose of the 8 patients who had both diagnostic DSA and interventions (eg, intra-arterial treatment of vasospasm and coiling of aneurysms) was 0.9 Gy (1.8-0.4 Gy). One patient had only CT examinations. There was no effort made to include or exclude the badge in the working view during interventions. CONCLUSIONS: It is feasible to incorporate a film badge that uses a visual scale to monitor the x-ray dose into the care of hospitalized patients. Cumulative skin doses in excess of 1 Gy were not uncommon (3/12) in this group of patients with acute SAH. This approach could provide a measure of the cumulative dose and is a convenient tool to quantify the effect of dose-reduction strategies.
BACKGROUND AND PURPOSE: While considerable attention has been directed to reducing the x-ray dose of individual imaging studies, there is little information available on the cumulative dose during imaging-intensive hospitalizations. We used a radiation-sensitive badge on 12 patients admitted with SAH to determine if this approach was feasible and to measure the extent of their x-ray exposure. MATERIALS AND METHODS: After obtaining informed consent, we assigned a badge to each of 12 patients and used it for all brain imaging studies during their ICU stay. Cumulative dose was determined by quantifying exposure on the badge and correlating it with the number and type of examinations. RESULTS: The average skin dose for the 3 patients who had only diagnostic DSA without endovascular intervention was 0.4 Gy (0.2-0.6 Gy). The average skin dose of the 8 patients who had both diagnostic DSA and interventions (eg, intra-arterial treatment of vasospasm and coiling of aneurysms) was 0.9 Gy (1.8-0.4 Gy). One patient had only CT examinations. There was no effort made to include or exclude the badge in the working view during interventions. CONCLUSIONS: It is feasible to incorporate a film badge that uses a visual scale to monitor the x-ray dose into the care of hospitalized patients. Cumulative skin doses in excess of 1 Gy were not uncommon (3/12) in this group of patients with acute SAH. This approach could provide a measure of the cumulative dose and is a convenient tool to quantify the effect of dose-reduction strategies.
Authors: M Cohnen; H-J Wittsack; S Assadi; K Muskalla; A Ringelstein; L W Poll; A Saleh; U Mödder Journal: AJNR Am J Neuroradiol Date: 2006-09 Impact factor: 3.825
Authors: E Stephen Amis; Priscilla F Butler; Kimberly E Applegate; Steven B Birnbaum; Libby F Brateman; James M Hevezi; Fred A Mettler; Richard L Morin; Michael J Pentecost; Geoffrey G Smith; Keith J Strauss; Robert K Zeman Journal: J Am Coll Radiol Date: 2007-05 Impact factor: 5.532
Authors: Amy Berrington de González; Mahadevappa Mahesh; Kwang-Pyo Kim; Mythreyi Bhargavan; Rebecca Lewis; Fred Mettler; Charles Land Journal: Arch Intern Med Date: 2009-12-14
Authors: G J Kemerink; M J Frantzen; K Oei; M Sluzewski; W J van Rooij; J Wilmink; J M A van Engelshoven Journal: Neuroradiology Date: 2002-05-03 Impact factor: 2.804
Authors: G Spilberg; S L Carniato; R M King; I M J van der Bom; M Mehra; R P Walvick; A K Wakhloo; M J Gounis Journal: AJNR Am J Neuroradiol Date: 2011-12-22 Impact factor: 3.825
Authors: E Vano; J M Fernandez; R M Sanchez; D Martinez; L Lopez Ibor; A Gil; C Serna-Candel Journal: AJNR Am J Neuroradiol Date: 2012-08-02 Impact factor: 3.825